Showing results (31-40 of 172) with videos related to
Sort By:
Pageof 18
Ophthalmic Plastic and Reconstructive Surgery|January 22, 2010
Treatment of benign lymphoid hyperplasia of the orbit with rituximabHao H Ho, Aaron Savar, Felipe Samaniego, et al.The American Journal of Dermatopathology|March 6, 2018
Cutaneous T-Cell Lymphoma, a Novel Manifestation of PDGFRA-Rearranged NeoplasmAmir Behdad, Pamela Allen, Xinyan Lu, et al.Cancer|June 24, 2005
Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphomaYasuhiro Oki, Peter McLaughlin, Barbara Pro, et al.Journal of Drugs in Dermatology : JDD|March 8, 2021
Clinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined With Phototherapy in Advanced Stage Mycosis FungoidesChristina J Walker, Maria L Espinosa, Neha Mehta-Shah, et al.Cancer Medicine|December 17, 2016
Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphomaFrancine Foss, Barbara Pro, H Miles Prince, et al.World Neurosurgery|May 4, 2020
Case Report of Immuno-Oncotherapy (IO) Provoked Encephalitis Mimicking Brain Metastasis in a Patient with History of Traumatic Brain InjuryShane P Bross, Gino J Mongelluzzo, Andrew R Conger, et al.Transplantation and Cellular Therapy|February 21, 2022
The Impact of a Hematopoietic Cellular Therapy Pharmacist on Clinical and Humanistic Outcomes: A RE-AIM Framework AnalysisBenjamin Andrick, Lorraine Tusing, Laney K Jones, et al.Journal of the American Academy of Dermatology|February 19, 2008
CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexateJustin J Leitenberger, Cindy N Berthelot, Kristel D Polder, et al.Journal of Hematology & Oncology|March 12, 2016
Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trialFrancine Foss, Steven Horwitz, Barbara Pro, et al.Cancer Journal (Sudbury, Mass.)|September 12, 2003
Importance of esophagogastroduodenoscopy in the evaluation of non-gastrointestinal mucosa-associated lymphoid tissue lymphomaBouthaina S Dabaja, Chul S Ha, Richard B Wilder, et al.Pageof 18